ANDA 62304, held by Arbor Pharms LLC. Erythromycin Ethylsuccinate.
As of Nov 16, 2026, ANDA 62304 (Pediamycin, Pediamycin 400), held by Arbor Pharms LLC, was first approved by FDA on Dec 18, 1980, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 18, 1980 | Original application | Approved | None posted |
| PediamycinEQ 200MG BASE/5ML · suspension;oral | Erythromycin Ethylsuccinate | Discontinued |
| Pediamycin 400EQ 400MG BASE/5ML · suspension;oral | Erythromycin Ethylsuccinate | Discontinued |
| Apr 28, 2016 | Supplement 32Labeling · Standard review | Approved | None posted |
| Aug 7, 2006 | Supplement 28Labeling | Approved | None posted |
| Oct 7, 2004 | Supplement 26Labeling | Approved | None posted |
| Oct 2, 2001 | Supplement 23Labeling | Approved | None posted |
| May 29, 2001 | Supplement 21Manufacturing | Approved | None posted |
| Mar 13, 2001 | Supplement 22Labeling | Approved | None posted |
| Nov 16, 2000 | Supplement 20Labeling | Approved | None posted |
| Dec 9, 1997 | Supplement 19Manufacturing | Approved | None posted |
| Oct 28, 1991 | Supplement 17Manufacturing | Approved | None posted |
| Dec 18, 1980 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters